Overall, current observations illustrated that in addition to glucose homeostasis, GCK also plays a crucial role in regulating lipid metabolism, and the inactivation of GCK may underlie the antiatherogenic profile associated with GCK-MODY. The gene discussed is GCK; the disease is MODY.